Masimo Corporation
Masimo Corporation Announces Preliminary Q4 and Full-Year 2025 Financial Results
Summary
Masimo Corporation announced select preliminary financial results for the fourth quarter and full-year ended January 3, 2026, projecting revenue growth and earnings per share that exceed expectations. The company expects Q4 revenue to be approximately $411 million with a 12% growth on a reported basis, and full-year revenue of approximately $1,523 million with a 9% growth on both reported and constant currency basis. Non-GAAP earnings per diluted share are expected to be more than $1.54 for Q4 and over $5.55 for the full year, reaching the high end of the guidance range. These results reflect the company's strategy execution and the value delivered to customers, with further details to be discussed in an investor call on February 26, 2026.
Profitelligence Alerts
Get alerts for MASI
Be first to know when Masimo Corporation files with the SEC.
Filing Categories
Advertisement
About Masimo Corporation
Masimo Corporation is a global leader in noninvasive monitoring technologies, specifically focusing on developing innovative medical devices that improve patient outcomes and reduce the cost of care. The company's flagship product line includes advanced signal processing pulse oximetry devices, which are pivotal in accurately measuring oxygen levels, pulse rate, and other vital signals without the need for invasive procedures. Masimo's technology is widely adopted across various healthcare settings including hospitals, outpatient treatment centers, and alternative care sites, enhancing patient monitoring and aiding clinicians in detecting potential health issues more efficiently. Besides, Masimo’s products are recognized for their precision and reliability, demonstrating robustness even in challenging clinical environments where motion and low perfusion can affect monitoring accuracy. The corporation is committed to expanding its technological suite, covering a spectrum of health monitoring solutions that contribute to improved healthcare practices globally. Based in Irvine, California, Masimo's ongoing innovation continues to set benchmarks in the healthcare industry, influencing a wide range of sectors from emergency care to surgical and critical care monitoring.
Official SEC Documents
Advertisement